A blood test can reveal just how severe a person’s food allergy is and could possibly replace more invasive testing, a new study published Wednesday morning suggests.
Around 4 to 6% of American children have food allergies, a risk the U.S. Centers for Disease Control and Prevention (CDC) calls “a growing food safety and public health concern.” However, determining whether someone has a food allergy and then determining just how severe that food allergy is can be tricky.
To assess whether someone has a specific allergy, doctors will perform skin pricks or blood tests to look for skin reactions or high levels of allergy-specific antibodies. But doctors still don’t have a simple tool to test just how allergic a person is to a specific food. In some cases, the individual will need to eat whatever food they are allergic to in the presence of a physician so the doctor can determine the severity of their allergy in a safe space.
Of course, that experience isn’t without patient anxiety, which is one of the reasons why researchers at Mount Sinai Health System studied whether a blood test could predict allergy severity and potentially replace any tests that require ingesting allergens. Their research is published in the journal The Annals of Allergy, Asthma & Immunology.
The test is called basophil activation test (BAT). It’s a blood test that measures the levels of an immune cell called basophil which is activated by food exposure. The researchers used the blood test on 67 people with food sensitivities between the ages of 12 and 45 while they also underwent an exposure test comparing their reactions to peanut, tree nut, fish, shellfish, or sesame versus a placebo. The allergens or placebo were given at random, and the goal was for the researchers to see if the results of the blood test corresponded to how the people reacted.
The test proved accurate, showing a high correlation with the BAT’s scores and the severity of the individuals’ reactions.
The researchers say the ultimate goal is to develop a new test that can become part of clinical allergy diagnoses in order to improve the quality of life for patients. “[This study] should encourage similar studies, which could lead to wide widespread clinical use,” says study author Dr. Xiu-Min Li, a researcher at the Icahn School of Medicine at Mount Sinai.
- The Fight to Save the Salmon
- Inside the World of Black Bitcoin, Where Crypto Is About Making More Than Just Money
- The 'Great Resignation' Is Finally Getting Companies to Take Burnout Seriously. Is It Enough?
- Suddenly, Everyone on TV Is Very Rich or Very Poor. What Happened?
- Colin Powell Reflects on His Mistakes in Unpublished TIME Interview
- Business Travel's Demise Could Have Far-Reaching Consequences
- If the U.S. Spends Big on Climate, the Rest of the World Might Follow